211 related articles for article (PubMed ID: 17121282)
1. Plasmepsin II inhibitory activity of alkoxylated and hydroxylated chalcones.
Sriwilaijaroen N; Liu M; Go ML; Wilairat P
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):607-12. PubMed ID: 17121282
[TBL] [Abstract][Full Text] [Related]
2. Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
Romeo S; Dell'Agli M; Parapini S; Rizzi L; Galli G; Mondani M; Sparatore A; Taramelli D; Bosisio E
Bioorg Med Chem Lett; 2004 Jun; 14(11):2931-4. PubMed ID: 15125962
[TBL] [Abstract][Full Text] [Related]
3. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
[No Abstract] [Full Text] [Related]
4. In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones.
Gutteridge CE; Hoffman MM; Bhattacharjee AK; Milhous WK; Gerena L
Bioorg Med Chem Lett; 2011 Jan; 21(2):786-9. PubMed ID: 21168330
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.
Geyer JA; Keenan SM; Woodard CL; Thompson PA; Gerena L; Nichols DA; Gutteridge CE; Waters NC
Bioorg Med Chem Lett; 2009 Apr; 19(7):1982-5. PubMed ID: 19250824
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of Plasmepsin II-potential antimalarial agents.
Corminboeuf O; Dunet G; Hafsi M; Grimont J; Grisostomi C; Meyer S; Binkert C; Bur D; Jones A; Prade L; Brun R; Boss C
Bioorg Med Chem Lett; 2006 Dec; 16(24):6194-9. PubMed ID: 17000102
[TBL] [Abstract][Full Text] [Related]
8. De Novo design, synthesis, and in vitro evaluation of a new class of nonpeptidic inhibitors of the malarial enzyme plasmepsin II.
Carcache DA; Hörtner SR; Bertogg A; Binkert C; Bur D; Märki HP; Dorn A; Diederich F
Chembiochem; 2002 Nov; 3(11):1137-41. PubMed ID: 12404641
[No Abstract] [Full Text] [Related]
9. In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin.
Frölich S; Schubert C; Bienzle U; Jenett-Siems K
J Antimicrob Chemother; 2005 Jun; 55(6):883-7. PubMed ID: 15824094
[TBL] [Abstract][Full Text] [Related]
10. Antiplasmodial activity of steroidal chalcones: evaluation of their effect on hemozoin synthesis and the new permeation pathway of Plasmodium falciparum-infected erythrocyte membrane.
Sisodia BS; Negi AS; Darokar MP; Dwivedi UN; Khanuja SP
Chem Biol Drug Des; 2012 Apr; 79(4):610-5. PubMed ID: 22248242
[TBL] [Abstract][Full Text] [Related]
11. Anti-plasmodial flavonoids from the stem bark of Erythrina abyssinica.
Yenesew A; Induli M; Derese S; Midiwo JO; Heydenreich M; Peter MG; Akala H; Wangui J; Liyala P; Waters NC
Phytochemistry; 2004 Nov; 65(22):3029-32. PubMed ID: 15504437
[TBL] [Abstract][Full Text] [Related]
12. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Hidaka K; Kimura T; Tsuchiya Y; Kamiya M; Ruben AJ; Freire E; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Jun; 17(11):3048-52. PubMed ID: 17400453
[TBL] [Abstract][Full Text] [Related]
13. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
Azim MK; Ahmed W; Khan IA; Rao NA; Khan KM
Bioorg Med Chem Lett; 2008 May; 18(9):3011-5. PubMed ID: 18417344
[TBL] [Abstract][Full Text] [Related]
14. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
15. Anti-plasmodial activity of Ailanthus excelsa.
Dell'Agli M; Galli GV; Parapini S; Basilico N; Taramelli D; Said A; Rashed K; Bosisio E
Fitoterapia; 2008 Feb; 79(2):112-6. PubMed ID: 18166279
[TBL] [Abstract][Full Text] [Related]
16. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
[TBL] [Abstract][Full Text] [Related]
17. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
18. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.
Valla A; Valla B; Cartier D; Le Guillou R; Labia R; Florent L; Charneau S; Schrevel J; Potier P
Eur J Med Chem; 2006 Jan; 41(1):142-6. PubMed ID: 16274873
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro.
Mishra N; Arora P; Kumar B; Mishra LC; Bhattacharya A; Awasthi SK; Bhasin VK
Eur J Med Chem; 2008 Jul; 43(7):1530-5. PubMed ID: 17977622
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]